Form 4: Emergent BioSolutions Executive Sells Shares to Cover Taxes

Coleen Glessner, an executive at Emergent BioSolutions, sold 18,674 shares of common stock to cover tax obligations.

Summary

• Coleen Glessner, an Executive Vice President at Emergent BioSolutions, sold 18,674 shares of the company's common stock on December 8, 2024.
• The sale was executed at a price of $9.01 per share.
• This transaction was conducted to cover tax obligations related to stock ownership.
• Following the transaction, Glessner directly owns 144,460 shares of Emergent BioSolutions common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives to manage their tax liabilities related to stock-based compensation. It is common for executives to sell shares to cover taxes.

Comparison to Industry Standards

• Executive stock sales for tax purposes are a common practice across publicly traded companies.
• The sale of 18,674 shares is not unusual for an executive at this level.
• The price of $9.01 per share is reflective of the current market value of the stock at the time of the transaction.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Emergent BioSolutions, stock sale, insider trading, executive, Form 4, tax obligations, share transaction